New Breast Cancer Treatment Approved

Article

WASHINGTON, D.C. - Officials at the Food and Drug Administration (FDA) have approved a new device for treating breast cancer.

The MammoSite Radiation Therapy System is an implanted catheter intended to treat women who had a cancerous lump removed in its early stages of development. The catheter sends radiation directly to the area where the lump was removed, avoiding radiating outlying tissue.

Manufactured by Proxima Therapeutics Inc., of Alpharetta, Georgia, the treatment option may last one to five days and is removed afterward. Although it is intended for all women, some may need whole-breast radiation for complete treatment.

Information from www.reuters.com

Recent Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content